Your session is about to expire
← Back to Search
Study Summary
This trial will test the effects of a new drug in healthy male subjects. The goal is to see if it is safe and tolerated, how it is processed by the body, and what effects it has.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Does this clinical trial offer participation for those aged 40 and above?
"This study demands that applicants meet the age criteria of 18 to 55 years old. For minors, there are an additional 50 studies available and 373 for those above pensionable age."
Are individuals able to participate in this experiment currently?
"Affirmative. Clinicaltrials.gov displays that this clinical research, initially published on August 23rd 2021, is currently seeking participants. The project necessitates recruiting 48 test subjects from a single medical centre."
Are there any potential risks associated with IA-14069?
"Due to the limited research surrounding IA-14069, our team has assigned a safety ranking of 1 on a scale from one to three. This is because this trial is currently in Phase 1 and there are only preliminary findings regarding efficacy and safety."
How many individuals are signed up for participation in this medical experiment?
"Affirmative. Clinicaltrials.gov's records confirm that this clinical trial is actively searching for participants, which was first published on August 23rd 2021 and revised most recently on September 6th 2022. A maximum of 48 patients will be accepted from one location."
Is there a predetermined demographic that is eligible for this clinical trial?
"This study is open to individuals aged between 18 and 55 with a BMI of between 18.0-32.0 kg/m2, body weight not less than 50kg, heart rate in the 40-100 beats per minute range, normal sinus rhythm, QT interval corrected by Fridericia's correction method to ≤450 milliseconds, QRS interval ≤120 milliseconds and PR interval ≤220 milliseconds; all indicating healthy cardiac conduction and function. In addition those wishing to participate must have signed an ICF form confirming their eligibility for inclusion as a healthy subject (hs)."
Share this study with friends
Copy Link
Messenger